544 Candesartan improves outcome in patients with low ejection fraction heart failure, irrespective of background dose of ACE inhibitor: a post-hoc analysis of the CHARM-Added trial
2006 ◽
Vol 5
(1)
◽
pp. 120-120
Keyword(s):
Post Hoc
◽
2018 ◽
Vol 71
(11)
◽
pp. A772
2011 ◽
Vol 57
(14)
◽
pp. E298
Keyword(s):
2015 ◽
Vol 65
(10)
◽
pp. A814
◽
2019 ◽
Vol 20
(1)
◽
pp. 73-80
◽